PACTR202308564052985

Optimal duration of bladder catheterization after elective caesarean section to prevent urinary tract morbidity: a randomized controlled trial of 12 versus 24 hours.

Dr Loretta Nnakwe·Not Applicable·Pan Africa Clinical Trials RegistryRecruitment Completed
Study focus
Disease/Condition
Obstetrics and Gynecology
Sponsor & location
Primary sponsor
Dr Loretta Nnakwe
Location
Nigeria
Timeline & enrollment
Phase
Not Applicable
Start date
Jan 01, 1900
End date
Jan 01, 1900
Summary

The rate of caesarean section has been on the rise worldwide due to its ability to prevent maternal and foetal morbidity and mortality. However, bladder catheterization during caesarean section can result in urinary tract morbidities. The optimal duration before removal of the catheter after caesarean section remains contentious and current practice is rather customary than global best practice guideline. The aim of this trial is to compare the post-operative morbidities associated with either 12-hour or 24-hour duration of bladder catheterization after elective caesarean section. Specific objectives include the prevalence of urine retention, significant bacturiuria, urinary tract infection and the pattern of post-operative recovery between both groups.

ICD-10 classifications
Obstetric and gynaecological devices associated with adverse incidentsObstructed labour due to other maternal pelvic abnormalitiesObstetric and gynaecological devices associated with adverse incidents : miscellaneous devices, not elsewhere classifiedObstetric and gynaecological devices associated with adverse incidents : diagnostic and monitoring devicesOther complications of obstetric surgery and procedures
Data source
Registry
Pan Africa Clinical Trials Registry
Trial ID
PACTR202308564052985
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for PACTR202308564052985 through Pure Global AI's free database. This Not Applicable trial is sponsored by Dr Loretta Nnakwe and is currently Recruitment Completed. The study focuses on Obstetrics and Gynecology.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.